Mkt Advisors LLC Abb Vie Inc. Transaction History

Mkt Advisors LLC

$225 Million
Q4 2024

A detailed history of Mkt Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mkt Advisors LLC holds 2,955 shares of ABBV stock, worth $597,146. This represents 0.23% of its overall portfolio holdings.

Number of Shares

2,955

Previous 3,039 2.76%

Holding current value

$597,146

Previous $600,000 12.5%

% of portfolio

0.23%

Previous 0.28%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$164.99 - $203.87 $13,859 - $17,125	-84 Reduced 2.76%	2,955 $525,000
Q3 2024 Oct 07, 2024	SELL	$163.84 - $199.33 $31,621 - $38,470	-193 Reduced 5.97%	3,039 $600,000
Q2 2024 Jul 12, 2024	SELL	$154.79 - $180.76 $7,120 - $8,314	-46 Reduced 1.4%	3,232 $554,000
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $2,237 - $2,549	-14 Reduced 0.43%	3,278 $596,000
Q4 2023 Jan 12, 2024	SELL	$137.6 - $154.97 $30,272 - $34,093	-220 Reduced 6.26%	3,292 $510,000
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $3,740 - $4,330	-28 Reduced 0.79%	3,512 $523,000
Q2 2023 Aug 01, 2023	SELL	$132.51 - $164.9 $28,224 - $35,123	-213 Reduced 5.68%	3,540 $476,000
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $1,879 - $2,165	13 Added 0.35%	3,753 $598,000
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $18,533 - $22,226	-134 Reduced 3.46%	3,740 $0
Q3 2022 Oct 20, 2022	SELL	$134.21 - $153.93 $4,563 - $5,233	-34 Reduced 0.87%	3,874 $520,000
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $275 - $349	2 Added 0.05%	3,908 $598,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $18,213 - $22,597	138 Added 3.66%	3,906 $590,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $404,796 - $512,184	3,768 New	3,768 $506,000

Others Institutions Holding ABBV

# of Institutions

4,095

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mkt Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mkt Advisors LLC with notifications on news.

Account